Document is current
Any future updates will be listed below
-
Authors
Lopes, Mariana Diz
Orsolini, Giovanni
Galvagni, Isotta
Rotta, Denise
Dartizio, Carmela
Benini, Camilla
Fassio, Angelo
Gatti, Davide
Viapiana, Ombretta
Rossini, Maurizio
Adami, Giovanni https://orcid.org/0000-0002-8915-0755
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 14 December 2025
First Online: 25 December 2025
Declarations
:
: The study was conducted according to the protocol REUMABANK approved by our local Ethics Committee, in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was collected for each participant.
: Patients provided consent for publication of anonymized data.
: Giovanni Adami has received advisory board honoraria, consultancy fees and/or speaker fees from Theramex, UCB, Lilly, Galapagos, Fresenius Kabi, Amgen, BMS, Abiogen and Pfizer. Davide Gatti has received advisory board honoraria, consultancy fees and/or speaker fees from Accord Health Care, Abiogen, Amgen, Eli-Lilly, Mereo, Neopharmed-Gentili, UCB. Maurizio Rossini reports advisory board honoraria, consultancy fees and/or speaker fees from AbbVie, ItalFrarmaco, Neopharmed-Gentili, Eli-Lilly, Theramex, UCB, outside the submitted work. Ombretta Viapiana has received advisory board honoraria and speaker fees from Gilead, Fresenius Kabi, Biogen, Eli-Lilly, UCB, Abbvie, MSD, BMS. Angelo Fassio reports personal fees from Abiogen, Novartis, Neopharmed. The other authors have disclosed no conflicts of interest.
